Skip to main content

Aptevo Therapeutics Inc 8-K, filed Nov 5, 2026

Aptevo Therapeutics Inc. (APVO)

8-K 2026-11-05 For: 2026-11-05
View Original
Added on November 05, 2026

About this 8-K

Aptevo Therapeutics Inc filed this 8-K on November 5, 2026.

Aptevo Therapeutics Inc. said successive priming-dose refinements for mipletamig substantially reduced infusion-related reactions, supporting preparations for Phase 2 development. AI summary

Items reported

  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits